C21 Investments Inc (CXXIF)
0.243
0.00 (0.00%)
USD |
OTCM |
Sep 20, 09:43
C21 Investments Net Income (Quarterly): -1.412M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -1.412M |
| January 31, 2024 | -2.042M |
| October 31, 2023 | -0.3761M |
| July 31, 2023 | -0.4161M |
| April 30, 2023 | -0.471M |
| January 31, 2023 | -2.119M |
| October 31, 2022 | 0.2485M |
| July 31, 2022 | 1.857M |
| April 30, 2022 | 0.3068M |
| January 31, 2022 | -1.993M |
| October 31, 2021 | 2.838M |
| July 31, 2021 | 4.062M |
| April 30, 2021 | 5.048M |
| January 31, 2021 | -8.305M |
| October 31, 2020 | 2.303M |
| July 31, 2020 | -0.0382M |
| April 30, 2020 | -2.628M |
| January 31, 2020 | -21.31M |
| October 31, 2019 | -5.156M |
| July 31, 2019 | -2.965M |
| April 30, 2019 | -3.127M |
| January 31, 2019 | -11.47M |
| October 31, 2018 | -3.552M |
| July 31, 2018 | -5.599M |
| April 30, 2018 | -1.023M |
| Date | Value |
|---|---|
| January 31, 2018 | -0.2246M |
| October 31, 2017 | -0.3284M |
| July 31, 2017 | -0.0354M |
| April 30, 2017 | -0.0113M |
| January 31, 2017 | -0.0135M |
| October 31, 2016 | -0.0135M |
| July 31, 2016 | -0.0148M |
| April 30, 2016 | -0.0117M |
| January 31, 2016 | -0.0144M |
| October 31, 2015 | -0.0115M |
| July 31, 2015 | -0.0287M |
| April 30, 2015 | -0.0146M |
| January 31, 2015 | -0.0098M |
| October 31, 2014 | -0.0177M |
| July 31, 2014 | -0.028M |
| April 30, 2014 | -0.0227M |
| January 31, 2014 | -0.1296M |
| October 31, 2013 | -0.0817M |
| July 31, 2013 | -0.0999M |
| April 30, 2013 | -0.0576M |
| January 31, 2013 | -0.1156M |
| October 31, 2012 | -0.0437M |
| July 31, 2012 | -0.6156M |
| April 30, 2012 | 0.0236M |
| January 31, 2012 | -0.1083M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-21.31M
Minimum
Jan 2020
5.048M
Maximum
Apr 2021
-1.558M
Average
-0.4161M
Median
Jul 2023
Net Income (Quarterly) Benchmarks
| Acasti Pharma Inc | -2.617M |
| Aurinia Pharmaceuticals Inc | 0.722M |
| Edesa Biotech Inc | -1.668M |
| Lexaria Bioscience Corp | -1.782M |
| Xenon Pharmaceuticals Inc | -57.92M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 6.596M |
| Total Expenses (Quarterly) | 7.436M |
| EPS Diluted (Quarterly) | -0.01 |
| Enterprise Value | 28.72M |
| Gross Profit Margin (Quarterly) | 30.79% |
| Profit Margin (Quarterly) | -21.41% |
| Earnings Yield | -15.06% |
| Operating Earnings Yield | 0.26% |
| Normalized Earnings Yield | -12.33 |